Biopharma News : Biopharma and Pharma news from all around the world :
- Takeda Announces Positive Results from Two Pivotal Phase 3 Studies of Oveporexton (TAK-861) in Narcolepsy Type 1
- U.S. FDA Approves KERENDIA® (finerenone) to Treat Patients With Heart Failure With Left Ventricular Ejection Fraction ≥40% Following Priority Review
- Samsung Bioepis’ European Whitepaper Proposes Solutions to Bridge Policy Gaps that Hinder Healthy Market Competition and Timely Access to Biosimilar Medicines
- Golden Age Health and Innostellar Biotherapeutics Sign Exclusive 10-Year Collaboration to Accelerate LX-101 Gene Therapy for Inherited Retinal Dystrophies due to RPE 65 gene mutation in Mainland China
- Amylyx Pharmaceuticals Presents New Exploratory Analyses from Phase 2 and Phase 2b Clinical Trials of Avexitide in Post-Bariatric Hypoglycemia at ENDO 2025
- Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SINOVAC Board Sets the Record Straight on July 8 Special Meeting of Shareholders
- Median Technologies Signs Financial Agreement for up to €37.5 Million New Financing Facility With the European Investment Bank (EIB)
- Walgreens Boots Alliance Shareholders Overwhelmingly Approve Transaction with Sycamore Partners
- CEL-SCI to Sign Partnership Agreement With Leading Saudi Arabian Pharma Company for Multikine in the Treatment of Head & Neck Cancer
- Oak Hill Bio Announces Publication of Rugonersen Phase 1 Study Results in Nature Medicine
- IDT Launches All-Inclusive Gene Fragments From 7 Cents Per Base With 25% Lower Turnaround Times and Next-Day Shipping Powered by Its Cutting-Edge Synthetic Biology Facility
- mRNA Cancer Vaccines Clinical Trials, Development Priority Status & Market Opportunity Insight 2025: Over 60 Candidates in Clinical Trials – ResearchAndMarkets.com
- Nordic Cold Chain Solutions Launches Nordic Express Pack: First Cold Chain Packaging Specifically Designed and Tested for GLP-1 Medications
- AIS Healthcare Recognized with URAC Leader in Performance Measurement Award
- Life Sciences BC Announces 2025 Awards Winners, Honouring Excellence in Health Innovation
- Qore Launches in Eddyville, Iowa, Ushering in Large-Scale Corn Processing for Bio-Based Solutions
- Geneoscopy Wins Patent Trial and Appeal Board Decision, Invalidating All 20 Claims of Exact Sciences’ ’781 Patent
- PharmaJet® Enters into MOU Agreement with Egyptian UPA and EVA Pharma to provide Needle-Free Delivery for Routine Immunization in Egypt
- Biocytogen Enters into Antibody Licensing Agreement with BeOne Medicines to Accelerate Innovative Drug Development
- Biocytogen Enters into Antibody Licensing Agreement with BeOne Medicines to Accelerate Innovative Drug Development
- AHF: Gilead’s Greed Costs Latin America HIV Protection
- Natera Presents Data at ESMO GI on its Tissue-Free Latitude™ MRD* Assay, Demonstrating Excellent Overall Performance in Colorectal Cancer
- KalVista Pharmaceuticals Announces FDA Approval of EKTERLY® (sebetralstat), First and Only Oral On-demand Treatment for Hereditary Angioedema
- Federal Court in Massachusetts Denies Vivo Capital’s Petition for Relief on SINOVAC
- Cancer Vaccine (Preventative, Therapeutic) Market Research 2021-2031 | Innovations Drives the Industry Forward – Precision Immunotherapy and Personalized Medicine in Focus – ResearchAndMarkets.com
- Sickle Cell Disease Treatment Market Research Report 2025-2035 | R&D Review, Patent Filling Trends, Regulatory Requirements, Pipeline Analysis – ResearchAndMarkets.com
- Immunomodulator Therapeutics Global Market Research 2024-2030 | R&D Investments Fuel Next-Gen Immunomodulator Development Amid Patent Expiry – ResearchAndMarkets.com
- Number of Shares and Voting Rights of Innate Pharma as of July 3, 2025
- InnoCare Announces Approval of Clinical Trial of a Novel ADC ICP-B794 in China
News about Biotech, Pharma, Biopharma, Medical Devices, Diagnostics, Digital Health
- Gerresheimer delivers solid results in the financial year 2024 despite market headwinds
- Straumann Group announces Executive Management Board changes
- Affluent Medical appoints Liane Teplitsky – a senior executive in the medical device industry as a new member of the Board of Directors
- Formycon receives regulatory approval in the UK for FYB203 (aflibercept), a biosimilar to Eylea®, under the brand name AHZANTIVE®
- Eckert & Ziegler Ensures Business Continuity After Cyber-Attack
- MeVis publishes figures for fiscal year 2023/2024 and forecast for 2024/2025
- Takeda Pharmaceutical Company Limited: Julie Kim Will Succeed Christophe Weber as CEO of Takeda in June 2026
- Lonza Delivers Solid 2024 Performance with CER Sales in Line with Prior Year and 29.0% CORE EBITDA Margin
- Abivax Publishes 2025 Financial Calendar
- Sartorius Stedim Biotech publishes preliminary, unaudited results for fiscal 2024
- Eckert & Ziegler Announces Preliminary Figures for 2024: Significant Increase in Sales and Adjusted EBIT
- Invitation to Straumann Group’s FYR 2024 analysts and media conference at Straumann Group Headquarters
- Invitation to Straumann Group’s 2024 full-year results webcast
- Pentixapharm Holding AG Closes the 2024 Financial Year With a Loss of EUR 14 Million, Including Risk Provisions for Myelo Amounting to EUR 7 Million
- Significant progress in all operating areas; stable fourth quarter leads to annual sales of EUR 12.2 million (+6%)
- Abivax Announces Presentation of Seven Abstracts for Obefazimod in Ulcerative Colitis at 2025 European Crohn’s and Colitis Organization 20th Annual Congress
- Galenica nominates Nadine Balkanyi-Nordmann for the Board of Directors
- Galenica reports strong sales growth once again
- Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) and (3) of the Regulation (EU) No 596/2014: Purchase of own shares – final notice
- Evotec receives grant from Korean Government to develop novel antibody-based treatments for lung diseases
- Relief Therapeutics Completes Strategic Transition with Sale of GOLIKE Rights ex-US
- SKAN announces preliminary key figures for the 2024 financial year
- MEDICLIN raises full-year guidance for the 2024 financial year
- DocMorris grows 6.7 per cent in 2024 and accelerates Rx growth in the fourth quarter
- Marinomed Biotech AG: Restructuring proceedings successfully completed
- Formycon receives EU approval for FYB203 (aflibercept), a biosimilar to Eylea®, under the brand names AHZANTIVE® and Baiama®
- Drägerwerk AG & Co. KGaA: Preliminary figures 2024: Net sales just below and earnings just above expectations – Forecast 2025
- Annual Report 2023/24: BRAIN Biotech AG acts from a strong cash position and is confident about its growth prospects
- Legalization of cannabis brings strong growth: Cantourage Group SE increases its sales by 118% to EUR 51.4 million in full year 2024
- Formycon and Fresenius Kabi announce MHRA approval for FYB202/Otulfi® (ustekinumab), a biosimilar to Stelara®
- Safest SARMs For Muscle Growth 2025: CrazyBulk Introduces Effective SARMs For Bulking, Cutting and Strength in USA.
- The New Science of Superhumans: The BioSport™ AI System Unlocks Hidden Athlete Potential
- AscellaHealth’s Patient-Focused Approach is Best-in-Class Model for Distribution of Rare Disease Therapies
- Aegle Therapeutics Names Industry Veteran Scott Braunstein, M.D. as Chairman of the Board
- Just Like Family Launches Compassionate Home Care Services in Newmarket, Aurora, and Bradford
- Circuit Clinical Partners with Western New York Medical to Expand Access to Clinical Trials in Buffalo
- Award-Winning Holixer from Natural Remedies Delivers Clinically Proven Sleep Support
- Evestia Clinical to merge with Atlantic Research Group
- Rani Therapeutics Holdings, Inc. Announces Pricing of $3.0 Million Registered Direct Offering
- Predictive Oncology Issues Shareholder Letter: Well Financed to Support Expanded U.S. Availability and E.U. Launch of ChemoFx® and Pursuit of Other High-Value AI-Driven Drug Discovery and Development Opportunities
- Myriad Genetics Earns 2025 Great Place To Work Certification™
- Organogenesis Applauds CMS Proposal to Reform Skin Substitute Payment Policy; Urges Refinements to Ensure Patient Access to Appropriate Products and Continued Innovation
- 4TEEN4 Announces Publication in European Journal of Heart Failure Demonstrating First-in-Human Shock Reversal Evidence for Procizumab in Three Compassionate Use Cases
- Draig Therapeutics Appoints Experienced Biotech Leader Douglas E. Williams, Ph.D. as Chair of its Board of Directors
- Rakovina Therapeutics Granted DTC Eligibility to Expand U.S. Investor Access
- Nixol Capsules Arrive in the UK: Harnessing Nature to Transform Weight Loss & Metabolic Health
- Topflight Pharma Development Veteran Joins Synendos
- Aquablation® Therapy’s Assigned Category I Code in 2026 Medicare Proposed Physician Fee Schedule
- Da Vinci’s Vitruvian Man Encodes the Blueprint of Human Evolution, Says London Dentist
- Da Vinci’s Vitruvian Man Encodes the Blueprint of Human Evolution, Says London Dentist
- Kane Biotech to Present at Advanced Wound Care Summit USA
- Kane Biotech to Present at Advanced Wound Care Summit USA
- Total Orthopedics and Sports Medicine Expands Multi-Specialty Spine and Orthopedic Care in New York
- Total Orthopedics and Sports Medicine Expands Multi-Specialty Spine and Orthopedic Care in New York
- ASAP Dental Care Marks Milestone in Dental Implants with Over 9,600 Procedures Performed
- ASAP Dental Care Marks Milestone in Dental Implants with Over 9,600 Procedures Performed
- Integra LifeSciences to Host Second Quarter 2025 Financial Results Conference Call on July 31, 2025
- Sanuwave Health Announces Preliminary Revenue Results for the Second Quarter 2025 (Ended June 30, 2025)
- Integra LifeSciences to Host Second Quarter 2025 Financial Results Conference Call on July 31, 2025
- Sanuwave Health Announces Preliminary Revenue Results for the Second Quarter 2025 (Ended June 30, 2025)
Sources for this page of Biopharma News : biopharma-reporter.com and worldpharmanews and pharmatimes.com and drugs.com and fiercepharma.com and scripintelligence.com and PR Newswire and Business Wire. Please visit all this very interesting websites for more info.
Biopharma News – Pharma News